Democratizing hedge fund level analysis tools for everyone
Name | Darya-Varia Laboratoria Tbk. |
Sector | Healthcare |
Industry | Pharmaceuticals & Health Care Research |
Code | F2 |
Latest Quarterly | 06-30-25 |
Name | Latest % | A Month Ago % |
---|---|---|
Blue Sphere Singapore PT. Ltd | 92.12 | 92.12 |
Public < 5% | 7.88 | 7.88 |
Others | 0.01 | 0.0 |
Source | 2022 | 2021 |
---|---|---|
Consumer Health Products | 50.9% | 55.2% |
Prescription Drugs | 37.5% | 33.3% |
Export & Toll | 10.2% | 11.5% |
Services | 1.4% | 0.0% |
Others | 0.0% | 0.0% |
Region | 2022 | 2021 |
---|---|---|
Indonesia | 90.8% | 89.4% |
International | 9.2% | 10.6% |
Others | 0.0% | 0.0% |
Valuation | Ratio | Rank |
---|---|---|
P/S | 0.85 | # 7 / 15 |
EV_EBITDA | 6.33 | # 3 / 15 |
PER | 7.47 | # 3 / 15 |
PBV | 1.19 | # 6 / 15 |
DER | 0.61 | # 6 / 15 |
Profitability | Ratio | Rank |
---|---|---|
NPM % | 11.2 | # 4 / 15 |
ROA % | 10.1 | # 6 / 15 |
ROE % | 15.6 | # 6 / 15 |
Year | DPS | Yield [%] |
---|---|---|
2024 | 108.0 | 6.8 |
2023 | 121.0 | 7.3 |
2022 | 116.0 | 4.9 |
2021 | 112.0 | 4.1 |
2020 | 107.0 | 4.4 |
Timeframe | Performance |
---|---|
1W % | -1.2 |
1Mo % | -2.1 |
3Mo % | 2.6 |
1Yr % | 7.0 |
Stocks | PER | Market Cap | EV | Revenue | EBITDA | Net Profit |
---|---|---|---|---|---|---|
DVLA | 7.47 | 1.88 T | 2.32 T | 2.17 T | 361 B | 243 B |
KLBF | 16.05 | 66.94 T | 68.47 T | 34,159 B | 5,862 B | 3,950 B |
SIDO | 13.49 | 15.00 T | 14.69 T | 3,657 B | 1,604 B | 1,201 B |
TSPC | 7.31 | 9.97 T | 8.89 T | 13,197 B | 1,807 B | 1,404 B |
SOHO | 16.51 | 8.88 T | 11.01 T | 10,338 B | 711 B | 581 B |
PYFA | -14.31 | 4.94 T | 10.68 T | 2,771 B | -27 B | -426 B |